개 아토피 피부염 시장 보고서(2026년)

Canine atopic dermatitis is a long-term, inflammatory skin disorder in dogs triggered by allergic reactions to environmental allergens like pollen, dust mites, mold, or certain foods. It is a hereditary condition that results in severe itching, skin redness, and frequent skin infections. The main goal of treating canine atopic dermatitis is to alleviate itching, decrease inflammation, and control secondary infections to enhance the dog's overall well-being.

The primary product categories used in the management of canine atopic dermatitis include glucocorticoids, antihistamines, immunosuppressants, monoclonal antibodies (mAbs), and other related therapies. Glucocorticoids are synthetic, broad-acting hormones that effectively relieve itching and inflammation by suppressing the immune response. This condition affects a variety of dog breeds, including German Shepherds, Terriers, Retrievers, and others, with common indications such as ectoparasites, food allergies, and allergic skin infections. Treatment methods include oral, topical, and injectable routes, and these products are distributed through veterinary clinics, retail pharmacies, online pharmacies, and other distribution channels.

Tariffs have impacted the canine atopic dermatitis market by increasing the cost of imported biologics, monoclonal antibodies, and specialty medications, which has affected veterinary clinics and pharmacies, particularly in North America and Europe. Segments like mAbs and immunosuppressants are most affected due to high import dependency. On the positive side, tariffs are driving local manufacturing initiatives, encouraging regional production of targeted therapies, and potentially improving supply chain resilience in the long term.

The canine atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides canine atopic dermatitis market statistics, including canine atopic dermatitis industry global market size, regional shares, competitors with a canine atopic dermatitis market share, detailed canine atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the canine atopic dermatitis industry. This canine atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The canine atopic dermatitis market size has grown rapidly in recent years. It will grow from $2.76 billion in 2025 to $3.05 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising prevalence of allergic skin conditions in dogs, growing awareness among pet owners and veterinarians, limited availability of targeted therapies in the past, adoption of glucocorticoids and antihistamines as primary treatments, expansion of veterinary dermatology services.

The canine atopic dermatitis market size is expected to see rapid growth in the next few years. It will grow to $4.5 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of novel biologics and mAbs, increasing investments in precision medicine for pets, rising adoption of topical and systemic immunotherapies, growth in online and retail distribution channels, focus on preventive and supportive care including nutraceuticals. Major trends in the forecast period include increasing use of monoclonal antibodies (mabs) for targeted therapy, growing adoption of allergen-specific immunotherapy (asit) in dogs, rising demand for medicated shampoos and topical treatments, expansion of nutraceuticals and probiotics for skin barrier support, focus on breed-specific treatment approaches for canine atopic dermatitis.

The growing number of skin allergy cases in dogs is expected to drive the expansion of the canine atopic dermatitis market. Skin allergies in dogs occur when their immune system overreacts to allergens like pollen, certain foods, or flea bites, leading to symptoms such as itching, redness, and irritation. This increase is partly due to greater exposure to environmental pollutants and allergens, which can trigger intensified immune responses and cause skin discomfort. Treatments for canine atopic dermatitis help alleviate these issues by minimizing inflammation and itching, as well as preventing secondary infections, thereby improving dogs' skin health and comfort. For example, in January 2024, the National Institutes of Health (NIH), a US-based government agency, reported that 7,915 dog owners (28.7%) indicated their dogs had experienced skin-related conditions. The data showed a steady increase in skin issues with age, from 7% in puppies to 37% in senior dogs. This rising prevalence is contributing to the growth of the canine atopic dermatitis market.

The increase in pet ownership is also contributing to the growth of the canine atopic dermatitis market. Pet ownership involves caring for domesticated animals, such as dogs, cats, and other companions, within a household setting. A key driver of this trend is the growing humanization of pets, where animals are increasingly seen as family members and sources of emotional support and companionship. Addressing canine atopic dermatitis plays an essential role in improving pets' lives by easing chronic itching and inflammation, enhancing skin health, and boosting overall comfort and well-being. For instance, in April 2025, the American Pet Products Association (APPA), a US-based trade association, reported that 94 million US households (71%) owned a pet, up from 86.9 million households (66%) in 2023-2024. As a result, the increase in pet ownership is fueling demand in the canine atopic dermatitis market.

Leading companies in the canine atopic dermatitis market are pursuing regulatory approvals to expand the global reach and availability of their treatments. Regulatory approvals are formal authorizations granted by health authorities after verifying that medical products meet safety, efficacy, and quality standards through comprehensive testing. For example, in September 2024, Elanco Animal Health Inc., a US-based pharmaceutical company focused on animal health, received US FDA approval for Zenrelia, a once-daily oral JAK inhibitor designed to treat allergic and atopic dermatitis in dogs. Zenrelia represents a significant innovation by addressing chronic, acute, or seasonal itching and inflammation with a single daily tablet. It functions by targeting the source of the itch and blocking the signaling pathways responsible for allergic reactions, thereby breaking the itch-scratch cycle. The treatment provides noticeable improvement from the first dose and helps minimize rebound itching, which is a common drawback in dogs treated with competing JAK inhibitors.

Major companies operating in the canine atopic dermatitis market are Merck & Co. Inc., Zoetis Inc., Hill's Pet Nutrition Inc., Royal Canin SAS, Ceva Sante Animale S.A., Virbac S.A., Elanco Animal Health Inc., Dechra Pharmaceuticals PLC, Vetoquinol S.A., Bioiberica S.A.U., Bimeda Animal Health Limited, Animal Dermatology Group Inc., Kindred Biosciences Inc., Nextmune AB, OKAVA Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Toray Industries Inc., LEO Pharma A/S, PetIQ Inc., Hester Biosciences Limited, Ourofino Saude Animal, Swedencare AB, Orion Corporation, Norbrook Laboratories Ltd., AB Science SA.

North America was the largest region in the canine atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the canine atopic dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the canine atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The canine atopic dermatitis market consists of sales of products including medicated shampoos, hypoallergenic diets, omega-3 fatty acid supplements, skin barrier repair creams, and topical antimicrobial or antifungal treatments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Canine Atopic Dermatitis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses canine atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for canine atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The canine atopic dermatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Glucocorticoids; Antihistamines; Immunosuppressants; Monoclonal Antibodies (mAbs); Other Products
• 2) By Dog Breed: German Shepherd; Terriers; Retrievers; Other Dog Breeds
• 3) By Indication: Ectoparasites; Food Allergy; Allergic Skin Infections; Other Indications
• 4) By Route Of Administration: Oral; Topical; Injectable
• 5) By Distribution Channel: Veterinary Clinics; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Glucocorticoids: Prednisone; Prednisolone; Dexamethasone; Methylprednisolone; Hydrocortisone; Triamcinolone
• 2) By Antihistamines: Diphenhydramine; Hydroxyzine; Cetirizine; Loratadine; Chlorpheniramine
• 3) By Immunosuppressants: Cyclosporine; Tacrolimus; Azathioprine; Mycophenolate Mofetil
• 4) By Monoclonal Antibodies: Lokivetmab; Investigational Monoclonal Antibodies
• 5) By Other Products: Essential Fatty Acid Supplements; Medicated Shampoos And Sprays; Allergen-Specific Immunotherapy (ASIT); Skin Barrier Repair Creams; Nutraceuticals And Probiotics
• Companies Mentioned: Merck & Co. Inc.; Zoetis Inc.; Hill's Pet Nutrition Inc.; Royal Canin SAS; Ceva Sante Animale S.A.; Virbac S.A.; Elanco Animal Health Inc.; Dechra Pharmaceuticals PLC; Vetoquinol S.A.; Bioiberica S.A.U.; Bimeda Animal Health Limited; Animal Dermatology Group Inc.; Kindred Biosciences Inc.; Nextmune AB; OKAVA Pharmaceuticals Inc.; Boehringer Ingelheim International GmbH; Toray Industries Inc.; LEO Pharma A/S; PetIQ Inc.; Hester Biosciences Limited; Ourofino Saude Animal; Swedencare AB; Orion Corporation; Norbrook Laboratories Ltd.; AB Science SA.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Canine Atopic Dermatitis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Canine Atopic Dermatitis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Canine Atopic Dermatitis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Canine Atopic Dermatitis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Use Of Monoclonal Antibodies (Mabs) For Targeted Therapy
  • 4.2.2 Growing Adoption Of Allergen-Specific Immunotherapy (Asit) In Dogs
  • 4.2.3 Rising Demand For Medicated Shampoos And Topical Treatments
  • 4.2.4 Expansion Of Nutraceuticals And Probiotics For Skin Barrier Support
  • 4.2.5 Focus On Breed-Specific Treatment Approaches For Canine Atopic Dermatitis

5. Canine Atopic Dermatitis Market Analysis Of End Use Industries

• 5.1 Veterinary Clinics
• 5.2 Retail Pharmacies
• 5.3 Online Pharmacies
• 5.4 Veterinary Hospitals
• 5.5 Pet Owners

6. Canine Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Canine Atopic Dermatitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Canine Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Canine Atopic Dermatitis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Canine Atopic Dermatitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Canine Atopic Dermatitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Canine Atopic Dermatitis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Canine Atopic Dermatitis Market Segmentation

• 9.1. Global Canine Atopic Dermatitis Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Glucocorticoids, Antihistamines, Immunosuppressants, Monoclonal Antibodies (mAbs), Other Products
• 9.2. Global Canine Atopic Dermatitis Market, Segmentation By Dog Breed, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• German Shepherd, Terriers, Retrievers, Other Dog Breeds
• 9.3. Global Canine Atopic Dermatitis Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ectoparasites, Food Allergy, Allergic Skin Infections, Other Indications
• 9.4. Global Canine Atopic Dermatitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Topical, Injectable, Other
• 9.5. Global Canine Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
• 9.6. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Glucocorticoids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prednisone, Prednisolone, Dexamethasone, Methylprednisolone, Hydrocortisone, Triamcinolone
• 9.7. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Diphenhydramine, Hydroxyzine, Cetirizine, Loratadine, Chlorpheniramine
• 9.8. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Immunosuppressants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cyclosporine, Tacrolimus, Azathioprine, Mycophenolate Mofetil
• 9.9. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lokivetmab, Investigational Monoclonal Antibodies
• 9.10. Global Canine Atopic Dermatitis Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Essential Fatty Acid Supplements, Medicated Shampoos And Sprays, Allergen-Specific Immunotherapy (ASIT), Skin Barrier Repair Creams, Nutraceuticals And Probiotics

10. Canine Atopic Dermatitis Market Regional And Country Analysis

• 10.1. Global Canine Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Canine Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Canine Atopic Dermatitis Market

• 11.1. Asia-Pacific Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Canine Atopic Dermatitis Market

• 12.1. China Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Canine Atopic Dermatitis Market

• 13.1. India Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Canine Atopic Dermatitis Market

• 14.1. Japan Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Canine Atopic Dermatitis Market

• 15.1. Australia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Canine Atopic Dermatitis Market

• 16.1. Indonesia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Canine Atopic Dermatitis Market

• 17.1. South Korea Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Canine Atopic Dermatitis Market

• 18.1. Taiwan Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Canine Atopic Dermatitis Market

• 19.1. South East Asia Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Canine Atopic Dermatitis Market

• 20.1. Western Europe Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Canine Atopic Dermatitis Market

• 21.1. UK Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Canine Atopic Dermatitis Market

• 22.1. Germany Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Canine Atopic Dermatitis Market

• 23.1. France Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Canine Atopic Dermatitis Market

• 24.1. Italy Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Canine Atopic Dermatitis Market

• 25.1. Spain Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Canine Atopic Dermatitis Market

• 26.1. Eastern Europe Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Canine Atopic Dermatitis Market

• 27.1. Russia Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Canine Atopic Dermatitis Market

• 28.1. North America Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Canine Atopic Dermatitis Market

• 29.1. USA Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Canine Atopic Dermatitis Market

• 30.1. Canada Canine Atopic Dermatitis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Canine Atopic Dermatitis Market

• 31.1. South America Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Canine Atopic Dermatitis Market

• 32.1. Brazil Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Canine Atopic Dermatitis Market

• 33.1. Middle East Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Canine Atopic Dermatitis Market

• 34.1. Africa Canine Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Canine Atopic Dermatitis Market, Segmentation By Product, Segmentation By Dog Breed, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Canine Atopic Dermatitis Market Regulatory and Investment Landscape

36. Canine Atopic Dermatitis Market Competitive Landscape And Company Profiles

• 36.1. Canine Atopic Dermatitis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Canine Atopic Dermatitis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Canine Atopic Dermatitis Market Company Profiles
  • 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Hill's Pet Nutrition Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Royal Canin SAS Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Ceva Sante Animale S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Canine Atopic Dermatitis Market Other Major And Innovative Companies

• Virbac S.A., Elanco Animal Health Inc., Dechra Pharmaceuticals PLC, Vetoquinol S.A., Bioiberica S.A.U., Bimeda Animal Health Limited, Animal Dermatology Group Inc., Kindred Biosciences Inc., Nextmune AB, OKAVA Pharmaceuticals Inc., Boehringer Ingelheim International GmbH, Toray Industries Inc., LEO Pharma A/S, PetIQ Inc., Hester Biosciences Limited

38. Global Canine Atopic Dermatitis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Canine Atopic Dermatitis Market

40. Canine Atopic Dermatitis Market High Potential Countries, Segments and Strategies

• 40.1 Canine Atopic Dermatitis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Canine Atopic Dermatitis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Canine Atopic Dermatitis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer